ExpreS2ion Set for Major Industry Events in September
ExpreS2ion Biotech Holding AB's subsidiary ExpreS2ion Biotechnologies ApS will participate in two major events this September. The first is BIOHK2026, the 5th Hong Kong International Biotechnology Conference and Exhibition, where they will join the Nordic Pavilion as a delegation of Nordic life science companies.
The event brings together global pharmaceutical companies like GSK, AstraZeneca, Novartis, Merck, Novo Nordisk, and Pfizer alongside Chinese biotechnology innovators. ExpreS2ion aims to use the conference for partnering meetings and business development discussions on their Drosophila S2 expression platform.
The second event is H.C. Andersen Capital Seminar on Danish Equities for Institutional Investors, where ExpreS2ion will present their clinical progress, partnered programs, platform activities, and financial position to private wealth, semi-institutional, and institutional investors.